Stocks
CONMED (CNMD) ROE US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | 7.96% | -10.8% | 7.73% | 13.8% | 4.55% | 5.39% | ||
| Changes by years, y/y, % | +7pp | -19pp | +19pp | +6pp | -9pp | +27.7% | |||
CONMED. ROE, %
CONMED. ROE, changes, pp
CONMED (CNMD) ROE US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| ROE, % | ? | 12.1% | 11.0% | 6.35% | 4.55% | 5.39% | 5.39% | |
| Changes by years, y/y, % | +3pp | 0pp | -8pp | -9pp | -7pp | |||
| Changes by quarters, q/q, % | -2pp | -1pp | -5pp | -2pp | +1pp | |||
